Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-01-18
2005-01-18
Goldberg, Jeanine (Department: 1634)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024310, C536S024330, C435S006120, C435S320100
Reexamination Certificate
active
06844431
ABSTRACT:
The present invention provides isolated nucleic acids encoding human SCA2 protein, or fragments thereof, and isolated SCA2 proteins encoded thereby. Further provided are vectors containing invention nucleic acids, probes that hybridize thereto, host cells transformed therewith, antisense oligonucleotides thereto and compositions containing antibodies that specifically bind to invention polypeptides, as well as transgenic non-human mammals that express the invention protein. In addition, methods for diagnosing spinocerebellar Ataxia Type 2 are provided.
REFERENCES:
patent: 5155218 (1992-10-01), Weinshank et al.
patent: 5552282 (1996-09-01), Caskey et al.
patent: 5650270 (1997-07-01), Giese et al.
patent: 5650277 (1997-07-01), Navot et al.
patent: 5741645 (1998-04-01), Orr et al.
patent: 5853995 (1998-12-01), Lee
patent: 5885834 (1999-03-01), Epstein
patent: 6251589 (2001-06-01), Tsuji et al.
patent: WO 9501437 (1995-01-01), None
patent: WO 9717445 (1997-05-01), None
patent: WO 9718224 (1997-05-01), None
Sahba et al. “Genomic Structure of the human gene for spinocerebellar ataxia type 2 (SCA2) on chromosome 12q24.1” Genomics, vol. 47, pp. 359-364, 1998.*
Chouhry et al. “CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms” Human Molecular Genetics. vol. 1, No. 21, pp. 2437-3446, Oct. 2001.*
Mizushima et al. “Analysis of spinocerebellar ataxia type 2 gnee and haplotype analysis (CCG)1-2 polymorphism and contribution to founder effect”. J. of Medical Genetics. vol. 36, No. 2, pp. 112-114, Feb. 1999.*
Sanpei et al. “Direct detection of expanded (CAG/CTG) repeats.” Biochemical and Biophysical Research Communications. vol. 212, No. 2 p. 341-346, Jul. 1995.*
IntelliGenetics Comparison of SEQ ID NO: 2 &4 and SEQ ID NO: 3& 5.*
GenBank Accession No. Y08262, Imbert et al. Sep. 1996.*
GenBank Accession No. T78912, Lutz et al. May 1997.*
GenBank Accession No. A62706, Tora et al. May 1997.*
GenBank Accession No. AA476524, Hillier et al. Jan. 1995.*
GenBank Accession No. L27350, Ambrose et al. 1994.*
GenBank Accession No. U70323, Pulst et al. 1996.*
GenBank Accession No. AF041472, Nechiporuk et al. Jan. 1998.*
Perkin-Elmer Biotechnology Catolog, 1992-1993, p. 11-12.*
Filla et al. “Has Spinocerebellar ataxia type 2 a distinct phenotype?” Neurology, Apr. 1995, p. 793-796.*
Banfi, et al., “Identification and characterization of the gene causing type 1 spinocerebellar ataxia,”Nature Genetics, 7,513-519 (1994).
Belal et al., “Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus,”Neurology, 44,1423-1426 (1994).
Brook, “Retreat of the triplet repeat,”Nat. Genet., 3,279-281 (1993).
Brunner et al., “Brief Report: Reverse Mutation In Myotonic Dystrophy,”New Engl. J. Med., 328,476-480 (1993).
Filla et al., “Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy,”J. Neurol., 239,351-353 (1992).
Gispert et al., “Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1,”Nat. Genet., 4,294-299 (1993).
Imbert, “Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expand CAG/glutamine repeats,”Nature Genetics, 14,285-291(1996).
Ioannou et al., “A new bacteriophage P1-derived vector for the propagation of large human DNA fragments,”Nat. Genet., 6,84-89 (1994).
Kawaguchi et al., “CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1,”Nat. Genet., 8,221-227 (1994).
Koide et al., “Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA),”Nat. Genet., 6,9-13 (1994).
Kremer, et al., “Mapping of DNA Instability at the Fragile X to a Trinucleotide Repeat Sequence p(CCG)n,”Science, 252,1711-1714 (1991).
Lopes-Cendes et al., “Confirmation of the SCA-2 Locus as an Alternative Locus for Dominantly Inherited Spinocerebellar Ataxias and Refinement of the Candidate Region,”Am. J. Hum. Genet., 54,774-781 (1994).
MacDonald et al., “A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntington's Disease Chromosomes,”Cell, 72,971-983 (1993).
Mahadevan, et al., “Myotonic Dystrohpy Mutation: An Unstable CTG Repeat in the 3′ Untranslated Region of the Gene,”Science, 255,1253-1255 (1992).
Mandel, “Questions of expansion,”Nat. Genet., 4,8-9 (1993).
Nagafuchi et al., “Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p,”Nat. Genet., 6,14-18 (1994).
Orr et al., “Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1,”Nat. Genet., 4,221-226 (1993).
Polo et al., “Heredetiary Ataxias and Paraplegias in Cantabria, Spain,”Brain, 114,855-866 (1991).
Pulst et al., “Anticipation in spinocerebellar ataxia type 2,”Nat. Genet., 5,8-10 (1993).
Pulst et al., “Genetic and Physical Map of the Spinocerebellar Ataxia 2 (SCA2) Region on Human Chromosome 12,”Neurology, 45,A422 (1995).
Pulst et al., “Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2,”Nature Genetics, 14,269-276 (1996).
Ranum et al., “Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11,”Nat. Genet., 8,280-284 (1994).
Rubensztein, et al., Phenotypic Characterization of Individuals with 30-40 CAG Repeats in the Huntington Disease (HD) Gene Reveals HD Cases with 36 Repeats and Apparently Normal Elderly Individuals with 36-39 Repeats,Am. J. Hum. Genet., 59,16-22 (1996).
Sanpei et al., “Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT,”Nature Genetics, 14,277-284 (1996).
Stevanin et al., “Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias,”Human Molecular Genetics, 5,1887-1892 (1996).
Takiyama et al., “The gene for Machado-Joseph disease maps to human chromosome 14q,”Nat. Genet., 4,300-304 (1993).
The WashU-Merck EST Project, “Soares parathyroid tumor NbHPAHomo sapienscDNA clone,” Accession No. W39162, May 15, 1996.
Trottier et al., “Polyglutamine expansions as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias,”Letters to Nature, 378,403-406 (1995).
Cedars-Sinai Medical Center
Goldberg Jeanine
LandOfFree
Nucleic acid encoding spinocerebellar ataxia-2 and products... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid encoding spinocerebellar ataxia-2 and products..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid encoding spinocerebellar ataxia-2 and products... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3372604